Pharming Group
Shantie Bansidhar has a diverse background in various industries, including pharmaceuticals, retail, and plant services. With experience in both labeling operations and artwork management, Shantie has held different positions such as Senior Manager, Manager, and Specialist. Shantie's education includes a degree in Administration and Tourism, showcasing a strong foundation in different areas.
This person is not in any offices
Pharming Group
Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (“HAE”) attacks in patients in Europe, the US, Israel, and South Korea.